Evidence map›Paper›PMID 32607420›Full record

ReviewTransplantation direct2020

Practical Considerations for Solid Organ Transplantation During the COVID-19 Global Outbreak: The Experience from Singapore.

Shimin Jasmine Chung, Ek Khoon Tan, Terence Kee, Thinesh Lee Krishnamoorthy, Ghee Chee Phua, Duu Wen Sewa, Boon-Hean Ong, Teing Ee Tan, Cumaraswamy Sivathasan, Huei Li Valerie Gan and 3 more

Abstract readReview
In one paragraph

Review in Transplantation direct, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Management of lung transplantation in the COVID-19 era-An international survey.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2021
    Article
  9. Article
  10. Impact of COVID-19 in solid organ transplant recipients.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2021
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Shimin Jasmine ChungDepartment of Infectious Diseases, Singapore General Hospital, Singapore.
Ek Khoon TanSingHealth Duke-NUS Transplant Centre, Singapore.
Terence KeeSingHealth Duke-NUS Transplant Centre, Singapore.
Thinesh Lee KrishnamoorthySingHealth Duke-NUS Transplant Centre, Singapore.
Ghee Chee PhuaSingHealth Duke-NUS Transplant Centre, Singapore.
Duu Wen SewaSingHealth Duke-NUS Transplant Centre, Singapore.
Boon-Hean OngSingHealth Duke-NUS Transplant Centre, Singapore.
Teing Ee TanSingHealth Duke-NUS Transplant Centre, Singapore.
Cumaraswamy SivathasanSingHealth Duke-NUS Transplant Centre, Singapore.
Huei Li Valerie GanSingHealth Duke-NUS Transplant Centre, Singapore.
Brian Kim Poh GohSingHealth Duke-NUS Transplant Centre, Singapore.
Prema Raj JeyarajSingHealth Duke-NUS Transplant Centre, Singapore.
Ban Hock TanDepartment of Infectious Diseases, Singapore General Hospital, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current coronavirus disease 2019 (COVID-19) pandemic has not only caused global social disruptions but has also put tremendous strain on healthcare systems worldwide. With all attention and significant effort diverted to containing and managing the COVID-19 outbreak (and understandably so), essential medical services such as transplant services are likely to be affected. Closure of transplant programs in an outbreak caused by a highly transmissible novel pathogen may be inevitable owing to patient safety. Yet program closure is not without harm; patients on the transplant waitlist may die before the program reopens. By adopting a tiered approach based on outbreak disease alert levels, and having hospital guidelines based on the best available evidence, life-saving transplants can still be safely performed. We performed a lung transplant and a liver transplant successfully during the COVID-19 era. We present our guidelines and experience on managing the transplant service as well as the selection and management of donors and recipients. We also discuss clinical dilemmas in the management COVID-19 in the posttransplant recipient.

Identifiers

PMID32607420
PMCPMC7266363

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.